Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.

Suppr

超能文献

作者信息

Kornprat Peter, Schöllnast Helmut, Cerwenka Herwig, Werkgartner Georg, Bernhardt Gerwin, Mischinger Hans-Jörg

出版信息

Int J Colorectal Dis. 2009 Jan;24(1):125-6. doi: 10.1007/s00384-008-0548-3. Epub 2008 Aug 6.

DOI:10.1007/s00384-008-0548-3

PMID:18682963

Abstract

摘要

相似文献

Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.

Int J Colorectal Dis. 2009 Jan;24(1):125-6. doi: 10.1007/s00384-008-0548-3. Epub 2008 Aug 6.

[Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].

Gan To Kagaku Ryoho. 2011 Sep;38(9):1541-3.

Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.

Eur J Surg Oncol. 2009 May;35(5):515-20. doi: 10.1016/j.ejso.2008.12.013. Epub 2009 Feb 5.

Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.

Ann Surg Oncol. 2010 Aug;17(8):2059-65. doi: 10.1245/s10434-010-0972-9. Epub 2010 Feb 23.

Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.

Clin Colorectal Cancer. 2006 Sep;6(3):202-7. doi: 10.3816/CCC.2006.n.036.

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.

J Clin Oncol. 2008 Nov 10;26(32):5254-60. doi: 10.1200/JCO.2008.17.7857. Epub 2008 Oct 14.

Recurrent disease four years after surgery and adjuvant chemotherapy.

Cancer Treat Rev. 2008;34 Suppl 2:S8-11. doi: 10.1016/S0305-7372(08)70003-3.

Neoadjuvant therapy with bevacizumab.

J Clin Oncol. 2006 Jun 1;24(16):2592-3; author reply 2593-4. doi: 10.1200/JCO.2005.05.2910.

[New concept on surgical management of liver metastases from colorectal cancer].

Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):401-3.

Sequential or combination chemotherapy for a patient with mCRC?

Cancer Treat Rev. 2008;34 Suppl 2:S12-6. doi: 10.1016/S0305-7372(08)70004-5.

引用本文的文献

Prospective Exploratory Phase I Clinical Trial Assessing the Safety of Preoperative Marking for Small Liver Tumors.

Cureus. 2023 Dec 15;15(12):e50603. doi: 10.7759/cureus.50603. eCollection 2023 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.

Int J Colorectal Dis. 2009 Jan;24(1):125-6. doi: 10.1007/s00384-008-0548-3. Epub 2008 Aug 6.

[Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].

Gan To Kagaku Ryoho. 2011 Sep;38(9):1541-3.

Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.

Eur J Surg Oncol. 2009 May;35(5):515-20. doi: 10.1016/j.ejso.2008.12.013. Epub 2009 Feb 5.

Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX.

Ann Surg Oncol. 2010 Aug;17(8):2059-65. doi: 10.1245/s10434-010-0972-9. Epub 2010 Feb 23.

Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.

Clin Colorectal Cancer. 2006 Sep;6(3):202-7. doi: 10.3816/CCC.2006.n.036.

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.

J Clin Oncol. 2008 Nov 10;26(32):5254-60. doi: 10.1200/JCO.2008.17.7857. Epub 2008 Oct 14.

Recurrent disease four years after surgery and adjuvant chemotherapy.

Cancer Treat Rev. 2008;34 Suppl 2:S8-11. doi: 10.1016/S0305-7372(08)70003-3.

Neoadjuvant therapy with bevacizumab.

J Clin Oncol. 2006 Jun 1;24(16):2592-3; author reply 2593-4. doi: 10.1200/JCO.2005.05.2910.

[New concept on surgical management of liver metastases from colorectal cancer].

Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):401-3.

Sequential or combination chemotherapy for a patient with mCRC?

Cancer Treat Rev. 2008;34 Suppl 2:S12-6. doi: 10.1016/S0305-7372(08)70004-5.

引用本文的文献

Prospective Exploratory Phase I Clinical Trial Assessing the Safety of Preoperative Marking for Small Liver Tumors.

Cureus. 2023 Dec 15;15(12):e50603. doi: 10.7759/cureus.50603. eCollection 2023 Dec.